UK cancer charity in deal with Cephalon Inc

Friday 19 March 2010

Cancer Research Technology (CRT), the technology transfer arm of the charity, Cancer Research UK, has reached an agreement with Cephalon Inc of the US to develop new small molecule drugs targeting members of the protein kinase C family.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom